3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
51
Gastrointestinal
8
Breast
8
Thoracic
6
Gynecologic
4
Endocrine
1
Conditions
Multiple Endocrine Neoplasia Type 1
3
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Obesity
1
Neuroendocrine Tumors
1
Motor Activity
1
Carcinoma, Neuroendocrine
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Interventions
atezolizumab
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
vandetanib
1
tivozanib
1
tipifarnib
1
temsirolimus
1
romidepsin
1
pembrolizumab
1
pasireotide
1
methyl hydroxyethyl cellulose
1
gadoteridol
1
gadoterate meglumine
1
gadolinium ethoxybenzyl DTPA
1
gadodiamide
1
gadobutrol
1
gadobenic acid
1
entinostat
1
Walking
1
Vinorelbine
1
Suramin
1
Standard of Care
1
Specimen Handling
1
Sirolimus
1
Ritonavir
1
Respiratory Therapy
1
Radiotherapy
1
Quality of Life
1
Patient Reported Outcome Measures
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Standard of Care
×
Endocrine
×
Clear all
NCT02957981
2023-09-13
GEM
Georgetown University
Phase NA
Completed
63 enrolled